Canada markets closed

XORTX Therapeutics Inc. (XRTX)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
2.5800-0.0200 (-0.77%)
At close: 04:00PM EDT
2.5000 -0.08 (-3.10%)
After hours: 05:28PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
0
0
0
0
0
-
Operating Expenses
Research Development
6,655
2,419
6,762
677.576
217.5845
-
Selling General and Administrative
4,674
2,228
2,399
1,616
624.4895
-
Total Operating Expenses
11,380
6,046
10,291
2,911
1,020
-
Operating Income or Loss
-11,380
-6,046
-10,291
-2,911
-1,020
-
Interest Expense
-
-
0
4.3905
10.5963
28.4888
Total Other Income/Expenses Net
13,844
3,634
2,468
1,336
23.0661
-
Income Before Tax
2,527
-2,158
-7,719
-1,579
-1,007
-
Income from Continuing Operations
2,527
-2,158
-7,719
-1,579
-1,007
-
Net Income
2,527
-2,158
-7,719
-1,579
-1,007
-
Net Income available to common shareholders
2,527
-2,158
-7,719
-1,579
-1,007
-
Basic EPS
-3.60
-1.09
-5.22
-1.44
-1.34
-
Diluted EPS
-3.60
-1.09
-5.22
-1.44
-1.34
-
Basic Average Shares
1,879
1,982
1,480
1,094
740.447
-
Diluted Average Shares
1,879
1,982
1,480
1,094
740.447
-